Filtrix Boss

❯ CEO of @Filtrix_Net
❯ Don't trade on FOMO. Trade data
❯ You're not a bad trader - you lack data
❯ Not Financial Advice

[Filtrix Boss @filtrixboss]

Open TDTH's 14 prior 5%+ gap-down sessions on https://t.co/gAuvSk5Mri and compare the median (+1.21%) with the mean (+4.28%). Do that before you call this a dip or a dump.

[Filtrix Boss @filtrixboss]

Trident Digital Tech is worth about $8M. This morning it completed a US$15 million equity offering, which it says brings September financing to approximately US$23 million to fund its "AI and Digital Infrastructure Strategy."

Those two numbers belong next to each other. One month of raising is roughly three times the market value. Because the money came from selling equity, existing holders now own a thinner slice of a company that is mostly new cash and new shares. $TDTH is -11.40% on tonight's scan.

#CAPS moved its balance sheet the other way today. It retired approximately 85% of its convertible note principal, leaving a $1 million balance. That removes a claim that could have turned into shares. TDTH went the opposite direction and issued the shares outright.

TDTH's own record doesn't fit the easy story. In 14 prior sessions that opened 5% or more below the prior close, half closed above the open and 43% closed below it. Fourteen sessions is a thin sample, and the median open-to-close was +1.21%.

[Filtrix Boss @filtrixboss]

Today's pitch: CPI "can rip on a date and still be a two-year hold."

The date part is real. The index prints on a schedule, every month, and the tape reacts that afternoon.

Nobody has ever bought shares of a consumer price index, though, so the only two-year hold in that sentence is the one sitting on your grocery receipt.

[Filtrix Boss @filtrixboss]

Pull the #IOVA gap-up history on https://t.co/rq3XhKNOrA and look at how wide those 19 sessions actually spread, not only which way they closed.

[Filtrix Boss @filtrixboss]

Two companies used the word guidance today, in opposite tenses.

#CCL says it outperformed guidance, with best-ever revenues, net yields and net income. That is a scorecard on a period that already happened.

Iovance raised its full-year 2026 revenue guidance to $410 to $420 million. That is management re-grading a year with a quarter still left to play. $IOVA is +34.94% on the upgrade, on a $5.0B company.

A raised range is a new estimate, not booked money. The tape pays for the forecast now. The fourth quarter supplies the proof later.

#IOVA's own record: 19 prior sessions that opened at least 5% above the prior close. 47% closed above that session's open, 53% below, with a median open-to-close of -0.84%. Today's +34.94% is measured from yesterday's close, so it doesn't tell you whether today qualified.

[Filtrix Boss @filtrixboss]

@stockplaymaker1 Shorts paying 36% to borrow shares that don't exist is the most expensive hobby on the tape. Let them fund it, and bank some into strength if $3 gives way.

[Filtrix Boss @filtrixboss]

Pull the 30%+ gap-down sample on https://t.co/z6itH6MFLY and look at the whole spread of open-to-close outcomes, not just the headline rate.

[Filtrix Boss @filtrixboss]

"Continued Slowing of Disease Progression."

That is uniQure's own headline on additional Phase I/II data for AMT-130 in Huntington's disease. $QURE is -44.69% before the bell on it.

The title and the quote don't actually contradict each other. "Slowing" tells you which way the needle moved. The price is reacting to how far it moved, and a headline adjective never supplies that number. The company writes the title. Whoever reads past it writes the gap.

The same pattern shows up this morning at #BYSI. Its headline carries an FDA Fast Track designation for plinabulin plus a "strategic transaction" to advance a Phase 3 trial, and it sits -25.89%. Two favorable headlines, two lower quotes.

If the gap-down holds into the open, the cross-stock record offers no rescue plan. Across 971 prior sessions where a stock opened 30% or more lower (price above $1), 59% closed below their own open and 40% closed above it. That record comes from other companies' sessions, and it gives no odds for this one.

The headline also says "ongoing." The studies aren't finished, and the headline doesn't settle the question.

[Filtrix Boss @filtrixboss]

@adamfeuerstein Sharp catch on the p-value quietly leaving the building at year 4, right as FDA review starts. On gaps down this big, only 40% close above the open. Anyone eyeing $QURE for a bounce should let the open prove it holds before touching it.

[Filtrix Boss @filtrixboss]

Pull Navitas's 31 prior gap-up sessions on https://t.co/v5p6EtVea6. A near-even split still hides a spread, and the spread is where the risk lives.

[Filtrix Boss @filtrixboss]

Navitas posted its headline at 4:15 PM ET, after the bell: "U.S. Government Selects Navitas to Develop Next-Generation 10 kV SiC Power Semiconductors."

The verb is develop, not supply or ship. The headline gives no dollar figure and no production schedule.

$NVTS is +14.24% after hours. This is a roughly $3.2 billion company with 200 million shares of float. It is a serious name moving on a named customer, not a float squeeze.

This morning's #SOAR headline ran the other way: $1.2 billion in orders from an unnamed "Large AI Customer," and it now sits on the loser side at -8.25%. One headline had a number without a buyer. This one has a buyer without a number.

Navitas's own record covers 31 prior sessions that opened with a gap-up of 5% or more. They split 48% closing above the open and 52% below, with a median of -0.69%. That history is close to a coin toss, and it shows no edge in either direction.

[Filtrix Boss @filtrixboss]

The $SMTC pitch today: a "very constructive higher low" that is "potentially being set," measured from the market low at the last FOMC.

The stock is -4.37% while the chalk mark goes up.

It's 3 PM, the low is still being made, and the tweet has already crowned it one of the best setups of the day. "Potentially" is holding up the whole trade.

[Filtrix Boss @filtrixboss]

Kandi published two press releases at the same minute this morning, 7:00 AM ET. One was first-half 2026 unaudited financial results. The other was a follow-on order for CATL heavy-truck battery swap stations. $KNDI is +32.65%.

The company wrote the key qualifier into its own headline: unaudited. No auditor has signed off on those half-year numbers yet. The follow-on order is a purchase commitment, not revenue already inside them. Two releases at the same timestamp produce one candle, but they are still two separate claims to check.

For scale, here is cross-stock history. Before-the-open earnings days that opened 30% or more higher: 82 prior sessions, and 67% of them closed below that session's open. That describes the sample, not today. An intraday gain also does not prove Kandi opened inside that bucket.

Last Thursday it was #INLF on first-half results: opened 6.25, closed 5.1, same session.

[Filtrix Boss @filtrixboss]

Pull SOAR's 20 prior gap-up sessions on https://t.co/x7ZhA3jb0G and read the close-versus-open column before this open adds another row.

[Filtrix Boss @filtrixboss]

An air-charter company worth about $10 million says its Alignment Engine subsidiary signed $1.2 billion in AI infrastructure orders. The headline identifies the buyer only as "Large AI Customer." The order book is roughly 120 times the company's market value, and the counterparty has no name.

$SOAR is up 79.83% before the bell. This ticker has 20 prior sessions that opened with a gap-up of 5% or more, and 17 of them closed below their open. That is the stock's own history. It is not today's odds.

#ZBAO shows the same buzzword moving the other way. It is down 15.80% after signing a definitive agreement to acquire NEXSYS TECH for a planned AI computing infrastructure business.

An order is a promise to buy. Revenue arrives after delivery. The headline names neither the customer nor a shipping schedule, so two blanks remain: who is buying and when anything ships.

[Filtrix Boss @filtrixboss]

@MartinShkreli Right question. 'Met the endpoint' isn't 'beat Eylea,' and with cheap biosimilar Eylea around, non-inferior won't sell. On opens gapped this hard, only 34% still close above the open. If you're in, trail it; if not, wait for the data tables.

[Filtrix Boss @filtrixboss]

The calendar books a dozen Fed speakers into the same week as PCE, payrolls and $MU earnings, all before the Oct 28 FOMC.

#MU sits at +0.42% while the microphones warm up.

Twelve people get to talk about the dial this week, and the only meeting that can turn it is still a month away.

[Filtrix Boss @filtrixboss]

Next week's calendar reads like a hotel wake-up list: PCE inflation Wednesday, nonfarm payrolls Friday, and Micron reporting after the bell.

$MU shows +0.42% heading into it, which is the sound of a clock being wound, not a bell being struck.

The headline's big reveal is that both reports "feed into rate expectations," and on Sunday the only thing anyone actually knows is what time the alarms are set for.

[Filtrix Boss @filtrixboss]

The NFP seismograph needle stays flat while the AI productivity claim demands a spike. The weekend gives you time to check whether the data actually matches the story you heard all week.

Review the actual print and your own journal entries before Monday's open.

[Filtrix Boss @filtrixboss]

Last week we flagged 2 hype tickers as statistical fades — 5-year base rates, not vibes.

This week the tape graded us:
$CTNT -9% · $NUWE -1%
2 of 2 faded.

Free Guide 2026-W39 is up. No vibes, just receipts.

👉 https://t.co/HB9HxwSW8j